Article
Licensed
Unlicensed
Requires Authentication
Measuring Rivaroxaban in a clinical laboratory setting, using common coagulation assays, Xa inhibition and thrombin generation
-
Pascal J. Molenaar
Published/Copyright:
March 30, 2012
Abstract
Background: Rivaroxaban, a direct Xa inhibitor, is one of the new oral antithrombotic agents for which laboratory monitoring is thought to be unnecessary in most cases due to predictable pharmacokinetics. Circumstances are conceivable, however, in which reliable laboratory testing of Rivaroxaban is desirable. The aim of the present in vitro study was to investigate and compare the analytical and practical use of Rivaroxaban monitoring with routine screening assays, thrombin generation and anti-Xa activity, in a clinical laboratory setting.
Methods: Rivaroxaban was added to nine normal donor plasmas and to a normal pooled plasma in concentrations up to 1000 μg/L. Prothrombin time (PT), activated partial thromboplastin time (APTT), endogenous thrombin potential (ETP) and anti-Xa activity were measured in all donor samples. Responsiveness to Rivaroxaban and imprecision of Rivaroxaban recovery were assessed.
Results: Low intra-, but high inter-individual imprecision was found for PT displaying a linear dose-response relationship. Imprecision was much lower when directly measuring anti-Xa activity. Responsiveness of ETP lag-time was high, but of total thrombin generation was low, illustrating that the main effect of Rivaroxaban Xa inhibition lies in delaying thrombin formation rather than in preventing it.
Conclusions: Despite a high inter-individual imprecision of the PT, this relatively fast and cost-friendly assay is sensitive to Rivaroxaban and integrates its effects on the global coagulant state of patients. Anti-Xa activity assays can be run to assess the actual Rivaroxaban concentration and in the future ETP could serve as a fine-tuned hemostatic balance indicator for patients using Rivaroxaban.
Received: 2012-1-26
Accepted: 2012-3-8
Published Online: 2012-03-30
Published in Print: 2012-10-01
©2012 by Walter de Gruyter Berlin Boston
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- Cancer epigenomics: moving slowly, but at a steady pace from laboratory bench to clinical practice
- Laboratory networking and sample quality: a still relevant issue for patient safety
- Reviews
- DNA methylation biomarkers and their utility for solid cancer diagnostics
- DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancer
- Global DNA hypomethylation in cancer: review of validated methods and clinical significance
- Genetics and Molecular Diagnostics
- δ0-Thalassemia in cis of βKnossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C→T) in thalassemia intermedia Tunisian patients
- Genetic-based reference values for angiotensin-converting enzyme (ACE) according to I/D polymorphism in a Spanish population sample
- General Clinical Chemistry and Laboratory Medicine
- Effects of sample transportation on commonly requested laboratory tests
- Long-term (in)stability of folate and vitamin B12 in human serum
- Information comparison of the effects of drugs on laboratory tests in drug labels and Young’s book
- First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis
- Antioxidant and oligonutrient status, distribution of amino acids, muscle damage, inflammation, and evaluation of renal function in elite rugby players
- Validation of the body fluid module on the new Sysmex XN-1000 for counting blood cells in cerebrospinal fluid and other body fluids
- Measuring Rivaroxaban in a clinical laboratory setting, using common coagulation assays, Xa inhibition and thrombin generation
- Cancer Diagnostics
- Increased concentrations of growth factors and activation of the EGFR system in breast cancer
- Infectious Diseases
- Incidence and significance of elevated lactate in the identification of critically ill patients
- Cardiovascular Diseases
- Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis
- Diabetes
- Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes
- Letters to the Editor
- Establishing professional phlebotomist group for quality control of the preanalytic variables of clinical laboratory
- Application of quality specification based on biological variation in planning quality control strategy
- Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab
- Comparison of relationships between FT4 and log TSH in Access DXI 800 Unicel, Modular E170 and ADVIA Centaur XP Analyzer
- Assay-specific pitfalls of catecholamine HPLC assays
- Evaluation of automated nucleated red blood cells counting on Sysmex XE5000 and Siemens ADVIA 2120
- Evaluation of the immature myeloid information (IMI) by Sysmex XE 2100® hematology analyzer in the identification of blasts of myeloid lineage
- Congress Abstracts
- Congress of Laboratory Medicine and Clinical Chemistry / 4th Annual Meeting of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC)
- Abstracts of the 2012 Convocation of Experts on Laboratory Quality / Embracing the Need of Continued Vigilance to Assure Quality Outcomes in the Modern Laboratory
Keywords for this article
anti-Xa activity;
BAY-59-7939;
coagulation assays;
Rivaroxaban;
thrombin generation
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- Cancer epigenomics: moving slowly, but at a steady pace from laboratory bench to clinical practice
- Laboratory networking and sample quality: a still relevant issue for patient safety
- Reviews
- DNA methylation biomarkers and their utility for solid cancer diagnostics
- DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancer
- Global DNA hypomethylation in cancer: review of validated methods and clinical significance
- Genetics and Molecular Diagnostics
- δ0-Thalassemia in cis of βKnossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C→T) in thalassemia intermedia Tunisian patients
- Genetic-based reference values for angiotensin-converting enzyme (ACE) according to I/D polymorphism in a Spanish population sample
- General Clinical Chemistry and Laboratory Medicine
- Effects of sample transportation on commonly requested laboratory tests
- Long-term (in)stability of folate and vitamin B12 in human serum
- Information comparison of the effects of drugs on laboratory tests in drug labels and Young’s book
- First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis
- Antioxidant and oligonutrient status, distribution of amino acids, muscle damage, inflammation, and evaluation of renal function in elite rugby players
- Validation of the body fluid module on the new Sysmex XN-1000 for counting blood cells in cerebrospinal fluid and other body fluids
- Measuring Rivaroxaban in a clinical laboratory setting, using common coagulation assays, Xa inhibition and thrombin generation
- Cancer Diagnostics
- Increased concentrations of growth factors and activation of the EGFR system in breast cancer
- Infectious Diseases
- Incidence and significance of elevated lactate in the identification of critically ill patients
- Cardiovascular Diseases
- Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis
- Diabetes
- Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes
- Letters to the Editor
- Establishing professional phlebotomist group for quality control of the preanalytic variables of clinical laboratory
- Application of quality specification based on biological variation in planning quality control strategy
- Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab
- Comparison of relationships between FT4 and log TSH in Access DXI 800 Unicel, Modular E170 and ADVIA Centaur XP Analyzer
- Assay-specific pitfalls of catecholamine HPLC assays
- Evaluation of automated nucleated red blood cells counting on Sysmex XE5000 and Siemens ADVIA 2120
- Evaluation of the immature myeloid information (IMI) by Sysmex XE 2100® hematology analyzer in the identification of blasts of myeloid lineage
- Congress Abstracts
- Congress of Laboratory Medicine and Clinical Chemistry / 4th Annual Meeting of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC)
- Abstracts of the 2012 Convocation of Experts on Laboratory Quality / Embracing the Need of Continued Vigilance to Assure Quality Outcomes in the Modern Laboratory
